companydata.dkEir Diagnostics ApS: Financial statements 2021
CVR: 40339396
Eir Diagnostics ApS (CVR 40339396) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,217,111 and a net result of DKK -469,005 compared with DKK -368,613 the year before. That is a decrease of 16.3% compared with the year before. Equity amounted to DKK 7,433,538. The solvency ratio was 84.3%.
- Gross Profit
- 1,217,111 kr.
- Profit/Loss
- -469,005 kr.
- Equity
- 7,433,538 kr.
- Total Assets
- 8,815,164 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 1.2 mio. | -469 t. | 7.4 mio. | - |
| 2020 | - | 1.5 mio. | -369 t. | 5.2 mio. | - |
Find more companies like Eir Diagnostics ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of November 11, 2021, Morten Lodberg Petersen has joined the board of directors of Eir Diagnostics ApS.
As of November 11, 2021, Preben Joffe has joined the board of directors of Eir Diagnostics ApS.
Eir Diagnostics ApS has published its annual report for 2020. Gross profit came to DKK 1,454,928, and the net result was DKK -368,613.
About Eir Diagnostics ApS
Eir Diagnostics ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2019. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named AptaZense ApS. The management consists of Tine Walldén Jespersen. The company's owners include Danmarks Tekniske Universitet, KEMPHANSEN HOLDING ApS and PLASTISENS ApS. In 2025, the company reported a gross profit of DKK 370,098 and a net result of DKK -16,645,537 compared with DKK -455,658 the year before. Equity amounted to DKK -4,205,596.